HALMY Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:44):

Stats
Today's Volume	1 274.00
Average Volume	12 122.00
Market Cap	10.58B
Last Dividend	$0.314 ( 2023-07-14 )
Next Dividend	$0 ( N/A )
P/E	35.90
ATR14	$0.396 (0.71%)

Halma plc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Halma plc Financials

Annual	2023
Revenue:	$1.85B
Gross Profit:	$877.90M (47.38 %)
EPS:	$0.620

FY	2023
Revenue:	$1.85B
Gross Profit:	$877.90M (47.38 %)
EPS:	$0.620

FY	2022
Revenue:	$1.53B
Gross Profit:	$724.30M (47.49 %)
EPS:	$0.650

FY	2021
Revenue:	$1.32B
Gross Profit:	$653.30M (49.56 %)
EPS:	$1.072

Financial Reports:

No articles found.

Halma plc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.280 (N/A)	$0.193 (N/A)	$0 (N/A)	$0 (N/A)	$0.314 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Halma plc Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.16 - Stable (3.28%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.260	2020-08-27
Last Dividend	$0.314	2023-07-14
Next Dividend	$0	N/A
Payout Date	2023-09-01
Next Payout Date	N/A
# dividends	7	--
Total Paid Out	$1.734	--
Avg. Dividend % Per Year	0.00%	--
Score	3.69	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.16
Div. Directional Score	8.73	--

Next Divdend (Est)
(2024-06-17)

$0.363 Estimate 3.65 %

Dividend Stability

0.29 Very Poor

Dividend Score

3.69

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
UBAB	Ex Dividend Junior	2023-06-29	Semi-Annually	0.00%
JUMSF	Ex Dividend Knight	2023-08-23	Semi-Annually	0.00%
BTVCY	Ex Dividend Junior	2023-06-01	Annually	0.00%
RNMBY	Ex Dividend Knight	2023-05-10	Annually	0.00%
FGFH	Ex Dividend Knight	2023-08-07	Quarterly	0.00%
WAKE	Ex Dividend Knight	2023-10-03	Quarterly	0.00%
MAAL	Ex Dividend Knight	2023-09-22	Quarterly	0.00%
CLVLY	Ex Dividend Knight	2023-09-07	Annually	0.00%
SLVYY	Ex Dividend Knight	2023-05-15	Semi-Annually	0.00%
HAWPY	Ex Dividend Knight	2023-08-22	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.123	1.500	7.53	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0847	1.200	7.18	8.61	[0 - 0.3]
returnOnEquityTTM	0.146	1.500	9.48	10.00	[0.1 - 1]
payoutRatioTTM	0.320	-1.000	6.80	-6.80	[0 - 1]
currentRatioTTM	2.68	0.800	1.603	1.282	[1 - 3]
quickRatioTTM	1.689	0.800	4.77	3.81	[0.8 - 2.5]
cashRatioTTM	0.422	1.500	8.77	10.00	[0.2 - 2]
debtRatioTTM	0.245	-1.500	5.92	-8.88	[0 - 0.6]
interestCoverageTTM	12.36	1.000	6.53	6.53	[3 - 30]
operatingCashFlowPerShareTTM	0.777	2.00	9.74	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.646	2.00	9.68	10.00	[0 - 20]
debtEquityRatioTTM	0.417	-1.500	8.33	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.493	1.000	5.12	5.12	[0.2 - 0.8]
operatingProfitMarginTTM	0.165	1.000	8.69	8.69	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.426	1.000	8.74	8.74	[0.2 - 2]
assetTurnoverTTM	0.686	0.800	8.76	7.01	[0.5 - 2]
Total Score				12.30

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	70.87	1.000	2.94	0	[1 - 100]
returnOnEquityTTM	0.146	2.50	9.67	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.646	2.00	9.78	10.00	[0 - 30]
dividendYielPercentageTTM	1.175	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.777	2.00	9.74	10.00	[0 - 30]
payoutRatioTTM	0.320	1.500	6.80	-6.80	[0 - 1]
pegRatioTTM	-3.54	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.152	1.000	8.70	0	[0.1 - 0.5]
Total Score				5.16

Halma plc

Halma plc, through its subsidiaries, provides technology solutions in the safety, health, and environmental markets. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire detection, specialist fire suppression, elevator safety, security sensors, people and vehicle flow technologies, specialized interlocks that control critical processes safely, and explosion protection and corrosion monitoring systems. This segment serves elevator safety, fire suppression, people and vehicle flow, fire detection, pressure management, industrial access control, and safe storage and transfer markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; water, air and gases monitoring technologies; instruments that detect hazardous gases and analyses air quality; and systems for water analysis and treatment. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; laboratory devices and systems that provide information to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable positive outcomes across clinical specialties. This segment serves the life sciences, health assessment, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.